Back to top
more

Surgery Partners (SGRY)

(Delayed Data from NSDQ)

$33.69 USD

33.69
5,241,283

+5.05 (17.63%)

Updated Aug 23, 2024 03:59 PM ET

After-Market: $33.75 +0.06 (0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (148 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Wall Street Analysts Predict a 35% Upside in Surgery Partners (SGRY): Here's What You Should Know

The consensus price target hints at a 34.6% upside potential for Surgery Partners (SGRY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Surgery Partners (SGRY) Reports Next Week: Wall Street Expects Earnings Growth

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ortho Clinical Diagnostics (OCDX) Tops Q4 Earnings and Revenue Estimates

Ortho Clinical (OCDX) delivered earnings and revenue surprises of 20% and 0.39%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Can Surgery Partners (SGRY) Climb 40% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 39.5% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Rimmi Singhi headshot

Save Your Portfolio by Getting Rid of These 4 Toxic Stocks

Investors who can spot the overpriced stocks and shun them at the right time are the ones likely to make a profit. SGRY, ASAI, BLKB and AZTA are a few toxic stocks that you should disown right away.

Surgery Partners (SGRY) Reports Q3 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -25.00% and 0.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Urmimala Biswas headshot

5 Medical Services Stocks Countering Industry Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most. However, falling healthcare spending may disrupt the trend.

Down 26.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Surgery Partners (SGRY)

Surgery Partners (SGRY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Surgery Partners (SGRY) Reports Break-Even Earnings for Q2

Surgery Partners (SGRY) delivered earnings and revenue surprises of 100.00% and -0.33%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -20.00% and 1.42%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day

David Bartosiak headshot

Bear of the Day: Surgery Partners (SGRY)

Somebody needs to come in and give earnings a boost, stat!

Are Options Traders Betting on a Big Move in Surgery Partners (SGRY) Stock?

Investors need to pay close attention to Surgery Partners (SGRY) stock based on the movements in the options market lately.

Surgery Partners (SGRY) Reports Q3 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -76.67% and 10.57%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Surgery Partners (SGRY) Q3 Earnings Expected to Decline

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

Urmimala Biswas headshot

Near-Term Outlook Tepid for Medical Services Industry

This sector witnesses growing demand for telemedicine-focused online medical services amid the pandemic.

Surgery Partners (SGRY) Reports Q2 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of 5.88% and 1.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Surgery Partners (SGRY) Q2 Earnings Expected to Decline

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of 41.38% and 16.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?